特应性皮炎
医学
皮肤病科
倍他米松
随机对照试验
药理学
内科学
作者
Thomas A. Luger,E.J.M. van Leent,Michael Graeber,S. Hedgecock,Mark Thurston,Albert Kandra,J. Berth‐Jones,Jens Roar Bjerke,Enno Christophers,J. Knop,André C. Knulst,Marie Morren,Adrian Morris,Sakari Reitamo,J Roed‐Petersen,Erwin Schoepf,K. Thestrup-Pedersen,P.G.M. van der Valk,J.D. Bos
标识
DOI:10.1046/j.1365-2133.2001.04134.x
摘要
1.0% SDZ ASM 981 cream, which was shown to be safe, well tolerated and the most effective concentration in this study, was selected as the concentration to be further developed in phase III studies.
科研通智能强力驱动
Strongly Powered by AbleSci AI